Bringing precision medicine to mental health

We empower clinicians through our platform to optimize medication selection/dose and track their patient’s response to treatment. Our pharmacogenomic test results along with patient reported outcome (PRO) software help facilitate a more personalized approach to treatment.

Contact us

The Tempus mental health platform

 

Many factors influence a patient’s treatment and response to medications. Pharmacogenomics (PGx) is an objective component to provide personalized treatment and improve clinical outcomes.

  • Tempus nP: The Tempus nP pharmacogenomic test informs medication selection and dosing for patients experiencing depression, anxiety, ADHD, and other mental health conditions.

  • Tempus PRO™: Your patient’s PGx results are a part of a comprehensive, data-driven platform designed to empower you to offer your patients precision mental health care. Every Tempus PGx report also includes access to Tempus PRO™ to track patient treatment response patterns.

A smarter path to remission

When standard treatment falls short, pharmacogenomic guidance can help improve the odds.

Up to 70% of patients may fail their 1st and 2nd depression medication. Almost 30% of these depression patients may never experience remission.1

Depression treatment informed by pharmacogenomic testing can be almost 2 times more effective than treatment as usual to achieve remission.2

Blue and dark grey blocks fill a grid, possibly representing data or progress.

Trusted by professionals, valued by patients.

dcnd

Dayton Center for Neurological Disorders

PGx is the future and I think what Tempus is doing is absolutely amazing to improve patients' lives. Tempus shows that their commitment to patients is absolutely unmatched, with unique technology delivered through Tempus PRO. I feel like we’re looking at the future of medicine, and I’m so excited for what is to come.

—Jon P. Durrani, DO, Neurologist
media-container-8

Pharmacogenomics (Pgx) test

 

Optimize medication selection and dosing 
with PGx insights

 

Evidence-based report

 

  • 13 clinically validated genes and 90+ variants

 

  • Citation links to FDA, and other expert consortia to maintain data transparency

 

  • Simple, actionable footnotes based on the latest PGx evidence

Pharmacogenomics (Pgx) test

 

Optimize medication selection and dosing 
with PGx insights

 

Report includes 110+ medications related to:

 

Depression, anxiety, bipolar disorder, ADHD/ADD, OCD, PTSD, schizophrenia, substance use disorder, sleep disorder (insomnia), eating disorders, and epilepsy

Pharmacogenomics (Pgx) test

 

Optimize medication selection and dosing 
with PGx insights

 

Emerging evidence

 

The science is rapidly and continuously evolving in the world of psychiatric genetics. Tempus is committed to helping providers stay up-to-date with the latest findings. While not considered clinically actionable yet, we provide emerging evidence results for you to consider for informational purposes. Emerging evidence genes include COMT, CACNA1C, MTHFR, DRD2, ABCB1, HTR2C, BDNF, and OPRM1

Pharmacogenomics (Pgx) test

 

Optimize medication selection and dosing 
with PGx insights

 

Convenient sample collection

 

A buccal swab is used for simplified sample collection. Sample collection kits may be mailed directly to patient homes.

Tempus PRO™→

Track adverse drug reaction and patient response to your selected treatment

Easily and accurately measure your patient’s response to your medical treatment with Tempus PRO™ as a part of the Tempus Mental Health Platform.

tempus notetaker→

Turn complex patient appointments into organized clinical notes in seconds.

Tempus Notetaker for psychiatry automates patient notes with precision, saving you time and burden so you can focus on quality patient care.

How it works

 

All Tempus tests must be ordered by a healthcare provider. Collection kits to obtain a buccal swab sample can be sent to your clinic or can be shipped directly to your patients. Our kits include easy-to-follow instructions and packaging for convenient and fast shipping to our lab.

media-container (6)

01

Order Tempus

 

  • Pharmacogenomic testing to help optimize medication selection and dosage

 

  • Your patients will be invited to use Tempus PRO™ to track their response to your selected treatment
media-container

02

Sample collection & Tempus PRO™ activation

 

  • Patient completes the buccal swab sample collection and sends the sample to Tempus via the included FedEx shipping label.

 

  • Patients can activate Tempus PRO™ and track various metrics to remain engaged in their progress in between appointments
media-container (8)

03

View your patient’s results

 

  • Log in to Tempus Hub at any time to see your patient’s combined pharmacogenomic and assessment result.

Patient payment information

 

DNA is complicated. Paying for DNA testing doesn’t have to be.

Tempus offers a transparent self-pay option of $295 for the Tempus nP test. We also accept government and in-network insurance. To help manage costs, we offer flexible payment plans, accept HSA/FSA, and provide financial assistance for eligible patients. If you have any questions, please call or text our Customer Success Team at 312-598-9961 or email help@tempus.com.

Have any questions?

Patient portal ↗︎
Online billing and consent form ↗︎
Billing and financial assistance →
Browse our FAQs →
FedEx shipping →

References

 

  1. Warden et al. 2007. The STAR*D Project Results-A Comprehensive Review of Findings
  2. Arnone et al. Effectiveness of pharmacogenomic tests including CYP2D6 and CYPC19 genomic variants for guiding the treatment of depressive disorders: Systematic review and meta-analysis of randomised controlled trials. Neurosci Biobehav Rev.2023 Jan;144:104965. doi:10.1016/j.neubiorev.2022.104965. Epub 2022 Dec 1. PMID:36463971.

This is AI-enabled precision medicine

This is the future of healthcare.